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INTRODUCTION
In 2017 alone, $12.7 billion was spent on 
clinical trial research, according to NIH. The 
basis for conducting these trials is often 
questionable, absent, or based in industry 
interest1. This research waste can be avoided 
by using systematic reviews (SR’s), which 
provide summaries of existing research and 
can be used to formulate effective research 
questions that have not been answered. In this 
study, we analyzed the scientific bases of 
randomized controlled trials (RCT’s) in 
Oromaxillofacial Surgery (OMFS) journals to 
determine if SR’s formed the basis of the 
research question.
OBJECTIVES
● Analyze randomly controlled clinical trials in 
OMFS journals for presence of SRs.
● Determine if SRs were used as basis of the 
trial.
● Characterize the source of funding, type of 
intervention, and type of trial conducted.
● Determine if variables were associated with 
the presence of SRs
METHODS
This study analyzed RCT’s in OMFS journals 
using the following criteria:
• Top 10-ranked journals by h5 index as of 
October 10, 2018.
• Published January 1, 2015 - December 31, 
2017
Two researchers independently screened each 
study to extract the following data:
• Location of SR cited.
• Number of SRs cited.
• Type of trial.
• Type of intervention.
• Source of funding.
• Number of participants.
Roughly half of the RCTs analyzed in this study 
cited an SR but less than half of those cited 
them as justification. Although there might have 
been justifications for the studies, they chose 
not to use the SRs. In some cases other RCTs 
were used as justification. As for how 
justification relates to funding, the highest use 
of SRs as justification were from trials funded by 
both a nonprofit and industry. This could be due 
to higher standards set forth by industry as they 
were the next highest for using SRs as 
justification. The lowest amount of justification 
was done in the nonprofit and no funding 
sectors.
SR Citations vs. SR Justification for Study
RCT Funding vs SR Justification for Study
Figure 1: A) Nearly half of the RCTs cited at least one SR in the introduction of the paper as can be seen above. B) But they 
were not always used to form the basis of the study. Less than half of the papers that cited the SR used the SR review as 
justification of the trial. 95% C.I.: 0.531+- 0.041 (0.490-0.572).
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Figure 2: A) The plurality of RCTs, 34.5%, did not report their funding with the next highest not receiving funding at 25.6%. The 
lowest reported values were self funded and combined nonprofit and industry. B) Interestingly, the funding source with the highest 
occurrence of RCTs using SRs as justification were from combined Industry and Nonprofit. Nonprofit and no funding had the lowest
occurrence of papers being justified by SRs.
